Breakthrough pancreatic cancer treatment could double survival time

A new study on a groundbreaking pancreatic cancer drug finds that it has the potential to double survival rates for more than 90 percent of patients. Researchers are now exploring whether the drug, called daraxonrasib, could also be effective in lung, ovarian, and colorectal cancers. NBC News’ Erika Edwards reports.

Source

NBC News

Read full article at NBC News

Opens original article in a new tab

Knicks’ Josh Hart knows he needs to make Spurs pay for potential Victor Wembanyama matchup

Josh Hart has a unique take on potentially being defended by Spurs unicorn Victor Wembanyama.

36 minutes agoRead more →

New York Post

Ricardo Pepi, Matt Turner forcing Mauricio Pochettino to rethink lineup with USMNT assumptions on hold

Maybe we should all stop assuming.

41 minutes agoRead more →

New York Post

Iran digs out underground missile sites during cease-fire with US: report

Iran has dug out a majority of the entrances to its underground missile bases that were buried by joint US-Israeli strikes during the height of the war, satellite images show.

about 1 hour agoRead more →

New York Post

Does Zendaya’s Rue live or die in the ‘Euphoria’ Season 3 finale?

“Euphoria” used to be a show about troubled high schoolers, but Season 3 turned into a deadly gangster drama. Does Zendaya's Rue make it out alive?

about 1 hour agoRead more →

Related General Stories

Knicks’ Josh Hart knows he needs to make Spurs pay for potential Victor Wembanyama matchup

Ricardo Pepi, Matt Turner forcing Mauricio Pochettino to rethink lineup with USMNT assumptions on hold

Iran digs out underground missile sites during cease-fire with US: report

Does Zendaya’s Rue live or die in the ‘Euphoria’ Season 3 finale?